G-CSF does not worsen toxicities and efficacy of CAR-T cells in refractory/relapsed B-cell lymphoma

Bone Marrow Transplant. 2020 Dec;55(12):2347-2349. doi: 10.1038/s41409-020-01006-x. Epub 2020 Jul 27.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antigens, CD19
  • Granulocyte Colony-Stimulating Factor
  • Humans
  • Immunotherapy, Adoptive
  • Lymphoma, B-Cell* / drug therapy
  • Receptors, Antigen, T-Cell
  • Receptors, Chimeric Antigen*
  • T-Lymphocytes

Substances

  • Antigens, CD19
  • Receptors, Antigen, T-Cell
  • Receptors, Chimeric Antigen
  • Granulocyte Colony-Stimulating Factor